Dr. Swetadri Vasan Setlur Nagesh, a researcher from the University at Buffalo’s Canon Stroke & Vascular Research Center (CSVRC), has received his first National Institutes of Health (NIH) R01 award. The grant will support the development of an innovative X-ray imaging technology that captures coronary blood flow details and has the potential to improve the diagnosis, assessment, and treatment of ischemic heart disease (IHD).

Dr. Setlur will build on his previous research using High-Speed 1000fps X-ray Angiography for neurovascular applications, including the visualization and quantitative assessment of how stents change blood flow in brain aneurysms with greater accuracy than currently available technology. While the technology continues to be developed for use in neuro care, this new project expands it to cardiovascular spaces. The effort will bring together expertise from across UB, including collaboration with faculty at the UB Department of Cardiovascular Medicine, UBNS Chairman Dr. Elad Levy, and CSVRC Director Dr. Adnan Siddiqui.

This new application could help address challenges in diagnosing and treating IHD. The disease can develop from both obstructive and non-obstructive coronary artery disease. While blocked arteries can be the cause, not all patients experiencing heart problems have stenosis and may instead be dealing with microvascular dysfunction, or a combination of both. 

Understanding how blood is actually flowing through the vessels could provide crucial information for helping these patients. While mathematical methods like Computational Fluid Dynamics (CFD) can estimate the blood flow inside a vessel, they are theoretical and can take a significant amount of time (from more than a few minutes to hours) to compute. 

What sets this R01-funded technology apart is that it allows the physicians to visualize and capture detailed actual blood flow patterns within the vessel while the patient is on the operating table. In current clinical interventional practice, there is no X-ray imaging technology that can provide such critical information.

“Our hypothesis is that with this camera, we should be able to detect effects of both stenosis as well as microvascular dysfunction on coronary blood flow, providing physicians with comprehensive functional information,” Dr. Setlur said. “That yes, [for example] this patient needs to be treated because the flow in this particular vessel is lower than normal.” 

Properly treating IHD can alleviate symptoms and reduce the risk of heart attacks and failure.

As Dr. Setlur and his team begin to further develop this technology, the grant itself represents a significant accomplishment. Securing an R01 is a notable and rare achievement in academic medicine, with only around 13% of applicants receiving one in 2025. 

“This is one of the most competitive milestones in academic research,” Dr. Levy said. “It's a testament to [Setlur’s] tenacity, discipline, and vision.”

Dr. Setlur would like to express his heartfelt appreciation to his mentors, Dr. Stephen Rudin, Dr. Siddiqui, and Dr. Levy, as well as his family, for their constant support and encouragement throughout this journey.